CurePSP Funds Mount Sinai’s Friedman Brain Institute Research Scholars Partnership in Honor of Karen Cook

$50,000 grant will support seed-funding initiative in brain research

NEW YORK–(BUSINESS WIRE)–CurePSP, the nonprofit advocacy organization for prime of life neurodegenerative diseases, has provided a $50,000 grant to Mount Sinai Health System for the 2020 Karen Strauss Cook Research Scholar Award.

The funds, made possible through the generosity of the Anna-Maria and Stephen Kellen Foundation, will support early-stage investigation into brain function and disease as part of Mount Sinai’s Friedman Brain Institute Research Scholars Partnership. The program is open to Mount Sinai faculty including early to mid-career investigators who seek to form new collaborations with colleagues in other disciplines and senior scientists who wish to undertake a project outside of their usual area of investigation. Projects are designed with the goal of generating the preliminary data needed to secure external funding from the National Institutes of Health (NIH) or other sources.

Lawrence I. Golbe, MD, CurePSP’s Director of Scientific Affairs, said, “We are very pleased to be supporting this initiative. The Mount Sinai program fits well with our own Venture Grants program, which provides seed funding to early career investigators who want to test innovative ideas. With success, these projects may lead to larger sources of funding to expand the research.”

Karen Strauss Cook was a Wall Street pioneer who was the first woman hired as a trader in the equities division at Goldman Sachs & Co. in New York and the third female finance professional at the firm. Later, she served as Chief Investment Officer at Steinhardt Partners, New York. Karen passed away in 2013 at age 61 from the effects of corticobasal degeneration (CBD), a rare neurodegenerative disease that is a focus of CurePSP-funded research.

David Kemp, President of CurePSP, said, “CurePSP is pleased to be honoring Karen’s memory in this meaningful way. Karen would have been very pleased to know that we are supporting Mount Sinai’s innovative research program.”

About CurePSP

CurePSP is the nonprofit advocacy organization for prime of life neurodegenerative diseases, a spectrum of fatal brain disorders that often strike during a person’s most productive and rewarding years. Since it was founded in 1990, CurePSP has funded more than 180 research studies and is a leading source of support and advocacy for patients, families, and other caregivers and education and information for doctors and allied healthcare professionals. CurePSP is based in New York City. Please visit www.curepsp.org for more information.

Contacts

David Kemp

President

[email protected]
802-734-1185

error: Content is protected !!